The Controversy of Atrucanumab and Impact of Alzheimer's Disease

This chapter explores the controversy surrounding the FDA approval of Atrucanumab, a new and expensive medication for Alzheimer's disease, highlighting concerns about its cost, efficacy, and lack of evidence. The discussion also delves into the significant impact of Alzheimer's disease on public health, caregiver challenges, historical perspectives, various subtypes of the disease, risk factors, lifestyle interventions, and the importance of weight management in relation to Alzheimer's.